Sleep Medicine
Volume 9, Issue 8 , Pages 818-822 , December 2008

Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam

  • Ingebjørg Gustavsen

      Affiliations

    • Division of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, NO-0403 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 23 40 78 00; fax: +47 23 40 78 78.
    • ,
  • Jørgen G. Bramness

      Affiliations

    • Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    • ,
  • Svetlana Skurtveit

      Affiliations

    • Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    • Department of Pharmacy, University of Tromsø, Norway
    • ,
  • Anders Engeland

      Affiliations

    • Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    • Department of Public Health and Primary Health Care, Section of Epidemiology and Medical Statistics, University of Bergen, Bergen, Norway
    • ,
  • Ineke Neutel

      Affiliations

    • Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Canada
    • ,
  • Jørg Mørland

      Affiliations

    • Division of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, NO-0403 Oslo, Norway
    • Institute of Pharmacology, University of Oslo, Oslo, Norway

Received 24 September 2007 ,Revised 12 November 2007 ,Accepted 13 November 2007.

References 

  1. Ohayon MM, Zulley J. Correlates of global sleep dissatisfaction in the German population. Sleep. 2001;24:780–787
  2. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006;29:1391–1397
  3. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry. 1985;42:225–232
  4. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. National Institute for Clinical Excellence; 2004.
  5. Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev. 1992;44:151–347
  6. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278:2170–2177
  7. Kassam A, Carter B, Patten SB. Sedative hypnotic use in Alberta. Can J Psychiatry. 2006;51:287–294
  8. Antai-Otong D. The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults. Perspect Psychiatr Care. 2006;42:196–200
  9. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction. 2003;98:1371–1378
  10. Busto UE, Sproule BA, Knight K, Herrmann N. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol. 2001;8:213–221
  11. Norwegian prescription database [Norwegian Institute of Public Health] [updated 2007 Sep 20]. Available from: http://www.reseptregisteret.no/.
  12. Neutel CI. Risk of traffic accident injury after prescription for a benzodiazepine. AEP. 1995;5:239–244
  13. Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol Clin Exp. 1998;13:115–123
  14. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136:873–883
  15. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31
  16. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352:1331–1336
  17. Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007;17:597–602
  18. Bramness JG, Skurtveit S, Morland J, Engeland A. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev. 2007;39:1050–1055
  19. Road traffic accidents [Statistics Norway] [updated 2007 Sep 20]. Available from: http://www.ssb.no/english/subjects/10/12/20/vtu_en/.
  20. Gambi F, Conti CM, Grimaldi MR, Giampietro L, De Bernardis B, Ferro FM. Flunitrazepam a benzodiazepine most used among drug abusers. Int J Immunopathol Pharmacol. 1999;12:157–159
  21. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev. 2004;8:309–325
  22. Kuitunen T, Mattila MJ, Seppala T, Aranko K, Mattila ME. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol. 1990;30:453–461
  23. Kuitunen T, Mattila MJ, Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol. 1990;5(Suppl 2):115–130
  24. Griffiths AN, Jones DM, Richens A. Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam. Br J Clin Pharmacol. 1986;21:647–653
  25. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol. 1993;13:100–106
  26. Verster JC, Volkerts ER, Schreuder AHCM, Eijken EJE, van Heucklum JHG, Veldhuijzen DS, et al. Residual effects of middle of-the-night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performance. J Clin Psychopharmacol. 2002;22:576–583
  27. Partinen M, Hirvonen K, Hublin C, Halavaara M, Hiltunen H. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med. 2003;4:553–561
  28. Staner L, Ertle S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, et al. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl). 2005;181:790–798
  29. Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep. 2002;25:224–231
  30. Berthelon C, Bocca ML, Denise P, Pottier A. Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?. J Psychopharmacol. 2003;17:324–331
  31. Montplaisir J, Hawa R, Moller H, Morin C, Fortin M, Matte J, et al. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol. 2003;18:29–38

PII: S1389-9457(07)00424-8

doi: 10.1016/j.sleep.2007.11.011

Sleep Medicine
Volume 9, Issue 8 , Pages 818-822 , December 2008

Article Tools